The Belgian embedded insurance orchestration platform, which backs Revolut, Mastercard, BMW, and Monzo, has tripled revenue over four years and now covers 15 million people across 32+ countries. Total funding crosses $100 million. Qover, the Belgian em…
The New York and Israel-based startup, founded by a former Run:ai engineer and professional triathlete, has grown 350%+ year-on-year and counts Adobe, Wiz, DocuSign, and Salesforce among its customers. Insight Partners led the Series C. ScaleOps has ra…
The Lausanne startup, spun out of EPFL’s robotics lab, has deployed 15 pods across Switzerland and made its first international move with a unit in Toulouse. Its founder’s longer-term ambition: making commercial real estate itself modular and on-demand…
A week that spanned semiconductor physics, orbital logistics, defence interceptors, and carob-based chocolate tells you something about the breadth of European and European adjacent capital right now. The dominant thread is not a single sector but a si…
The unsecured facility, arranged with JPMorgan Chase, Goldman Sachs, Mizuho, SMBC and MUFG, matures in March 2027. Once SoftBank’s $30B follow-on investment in OpenAI closes, its cumulative stake will total approximately $64.6B, representing roughly 13…
The London-based proptech, which combines a proprietary robotic camera with an AI software stack to produce a full property media kit from a single visit, has closed its Series B led by Cipio Partners. The premise behind Giraffe360 is straightforward: …
The startup, spun out of nonprofit Accumulus Synergy last August, has built a network connecting pharmaceutical and biotech companies to regulators across more than 70 countries. The new Connector makes that network accessible without leaving the syste…
The Italian foodtech, which makes Choruba from Mediterranean carob and has already signed four European confectionery partnerships, now has €9.4M in total funding to push commercial expansion and develop an organic product line. Foreverland, the Italia…
The London-based platform, which already covers 1.5 million eligible lives across enterprise and healthcare deployments, is using the Series A to accelerate US market entry and deepen its clinical infrastructure, with a new CEO who sold his last compan…
The Munich startup is building what it calls a ‘context graph’, a continuously updated map of how operational decisions actually get made inside an enterprise, drawn from millions of real cases rather than documentation that may never have been written…